custom image

Proteomics in Cell Biology and Disease

September 21-23, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change


Proteomics provides critical biological information about the activation state of enzymes, pathways, and signaling networks that drive all biological processes. However, the power of this approach is currently limited by the capabilities of proteomics technologies and methods. Although single dimensional proteomics analysis is now routine on abundant samples, challenges remain in analyzing limited samples collected from in vivo studies and in examining dynamic cellular processes. This meeting aims to address these challenges, focusing on the latest advances and innovations in sample preparation, instrumentation, and bioinformatic/computational analysis, to push the boundaries of proteomics to enable more powerful analytics for translational research.

Specifically, the program will cover:

  1. Cutting edge sample preparation methods that enable increased sensitivity and functional analysis of proteins
  2. Approaches to tackle single cell proteomics analysis, in parallel with genomics and transcriptomics advances
  3. Advancing multiplex capabilities beyond 2-10 plex experimentation to for more meaningful clinical analysis
  4. Integration of various “omics” data sets with proteomics to provide a more global view of the dynamic cellular environment

A critical focus of this virtual meeting will be on new technologies needed to further improve the feasibility of looking at multicellular dimensions & multiplexed analyses in proteomics. The program features diverse content on current biological applications and needs, highlighting the application of high sensitivity proteomics to real-world translational questions. Participants will learn what instrumentation, data acquisition methods, and informatic pipelines allow researchers to answer critical yet challenging questions, while also learning what is not yet feasible. By bringing together a multidisciplinary team of experts across a broad range of fields through digital technologies, this virtual meeting aims to stimulate a collaborative environment and cross-pollination of ideas to drive the next wave of innovation in proteomics approaches and technologies. We will also discuss how we can better work together as a community to disseminate these methods and analytical tools, similar to recent movements in the open source computational programming world. Ultimately our goal is to help build a proteomics community that is ready to tackle even the most complex biological problems.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Pricing:

Registration for this meeting is now closed.

Deadlines:

Scholarships: Passed
Abstract Submission: Passed

#VKSproteomics21




Program Details



Speaking at this eSymposia


Nathalie Agar

Brigham and Womens Hospital, USA


Marcus Bantscheff

GlaxoSmithKline, Germany


Matthew S. Bogyo

Stanford University School of Medicine, USA


Jyoti Choudhary

Institute of Cancer Research, UK


Claudia Andrea Escher

Biognosys AG, Switzerland


Anne-Claude Gingras

Lunenfeld-Tanenbaum Research Institute, Canada


Joseph Gogain

SomaLogic, Inc, USA


David E. James

University of Sydney, Australia


Ryan Kelly

Brigham Young University, USA


Jennie R. Lill

Genentech, Inc., USA


Kathryn S. Lilley

University of Cambridge, UK


Cecilia Lindskog

Uppsala University, Sweden


Edward M. Marcotte

University of Texas at Austin, USA


Lennart Martens

Ghent University, Belgium


Nadia Martinez-Martin

Genentech, Inc., USA


Mikhail Savitski

European Molecular Biology Laboratory, Germany


Alice Y. Ting

Stanford University, USA


Matthias Trost

Newcastle University, UK


Olga Vitek

Northeastern University, USA


Jonathan S. Weissman

University of California, San Francisco, USA


Forest M. White

Massachusetts Institute of Technology, USA


Bernd Wollscheid

ETH Zürich, Switzerland


Gavin J. Wright

Wellcome Trust Sanger Institute, UK








Additional Support



custom image

custom image

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation




Media In-Kind Sponsors



EMBO

JEM and JCB

Frontiers

custom image





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Donate to Keystone Symposia


custom image